The Blurring Boundaries of Elder Care: Implications for Providers and Patients
Healthcare providers are planning to invest in home health, palliative and end-of-life care, and geriatric caretakers in the coming years.
Trump Administration’s Plan to Boost Choice, Competition Draws Hospital Concerns
Dec. 4—An expansion of site-neutral payments, support for physician-owned hospitals, and changes to graduate medical education (GME) were among the newly revealed Trump administration priorities that drew early hospital opposition.
Dec. 3-7: Hospitals Expected to Face Growing Margin Pressure
Nov. 29—Policymakers in Washington, D.C., next week will focus on hospitals' Medicare margins, as one rating agency warns government- and consumer-driven margin pressure will increase.
Work: The Cure For Political Overload
HFMA President and CEO Joe Fifer discusses why today’s healthcare challenges transcend politics—and the implications for healthcare finance leaders.
Taking a Holistic View of Procure-to-Pay
An in-depth look at how one company is enabling more efficient procure-to-pay processes to streamline healthcare organizations’ financial operations.
The 2018 Midterm Elections: Implications for Health Care
The healthcare industry could see some significant changes now that the balance of power in Washington D.C. has shifted.
Rethinking Revenue Cycle Management
Fully managed revenue cycle functions present challenges and opportunities. When successful, they better align with an organization’s clinical and financial goals.
Why Your Access Strategy Demands Pricing Transparency
Consumers have come to expect price transparency in health care, which has greatly increased the strategic and operational importance of providers’ charge master descriptions and other pricing frameworks.
Current Forces Shaping the Technological Landscape
Factors that are driving the increasing use of digital technology in health care include consumer expectations for cost transparency and a new outcomes-based payment and delivery models.
The Conscience of the Generic Drug Market
Created to address the high costs and shortages of generic medications, the not-for-profit generic drug manufacturer Civica Rx aims to be a societal asset by providing patients across the nation with affordable access to the medications they need.